For Critically Ill Patients With Hematological Malignancy, Early, Aggressive Treatment Recommended

Main Category: Blood / Hematology
Also Included In: Transplants / Organ Donations;  Lymphoma / Leukemia / Myeloma;  Infectious Diseases / Bacteria / Viruses
Article Date: 25 Aug 2009 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:2 stars

2 (1 votes)


A study of 7,689 admissions from 178 adult intensive care units in England, Wales and Northern Ireland has revealed the factors associated with a higher mortality rate in haematological malignancy. Researchers writing in BioMed Central's open access journal Critical Care found that certain factors have a significant impact on the risk of death.

Haematological malignancy refers to a range of conditions resulting from the malignant transformation of bone marrow cells. Dr. Peter Hampshire, from Glan Clwyd Hospital, North Wales, worked with a team of researchers from the UK Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme Database (http://www.icnarc.org/) to analyse high quality data from a 12-year period, relating admission characteristics to outcome in critically ill patients with haematological malignancy.

Intensive care unit mortality was 43.1% (3312 deaths) and acute hospital mortality was 59.2% (4239 deaths). Mortality increased with the number of organ failures on admission. Factors associated with an increased risk of death included bone marrow transplantation, Hodgkin's lymphoma, severe sepsis, age, a low haematocrit and length of hospital stay before intensive care admission. Artificial ventilation, however, was not associated with increased mortality, in contrast to previous studies.

Dr Hampshire said, "Historically these patients have had a very high mortality if they become sick enough to need intensive care. We conclude that, if appropriate, such patients should be treated aggressively with early intensive care unit admission".

Notes:
Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general Critical Care units: a secondary analysis of the ICNARC Case Mix Programme Database
Peter A Hampshire, Catherine A Welch, Lawrence A McCrossan, Katharine Francis and David A Harrison
Critical Care (in press)
http://ccforum.com/

Source:
Graeme Baldwin
BioMed Central

Article adapted by Medical News Today from original press release.
Visit our blood / hematology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Graeme Baldwin. "For Critically Ill Patients With Hematological Malignancy, Early, Aggressive Treatment Recommended." Medical News Today. MediLexicon, Intl., 25 Aug. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/161773.php>

APA
Graeme Baldwin. (2009, August 25). "For Critically Ill Patients With Hematological Malignancy, Early, Aggressive Treatment Recommended." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/161773.php.

Please note: If no author information is provided, the source is cited instead.


Blood / Hematology

What is Hemophilia?

Hemophilia is a group of inherited blood disorders in which the blood does not clot properly. Bleeding disorders are due to defects in the blood vessels, the coagulation mechanism, or the blood platelets. Read more...

Most Popular Articles



Follow Our Blood News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Blood / Hematology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »